Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 9;23(1):86.
doi: 10.1186/s12894-023-01222-9.

Influence of TPH2 and HTR1A polymorphisms on lifelong premature ejaculation risk among the chinese Han population

Affiliations

Influence of TPH2 and HTR1A polymorphisms on lifelong premature ejaculation risk among the chinese Han population

Fei Wang et al. BMC Urol. .

Abstract

Background: Lifelong premature ejaculation (LPE) is one of the most common ejaculatory dysfunctions in men. The serotonin (5-HT) synthesis rate-limiting enzyme (TPH2) and receptor (HTR1A) in the 5-HT regulatory system may play a key role in the pathogenesis of LPE. However, there are few studies on the effects of TPH2 and HTR1A polymorphisms on LPE risk. We speculated that TPH2 and HTR1A polymorphisms may affect the occurrence and development of LPE in the Chinese Han population.

Methods: In this study, 91 patients with LPE and 362 normal controls aged 18 to 64 years were enrolled in the male urology department of Hainan General Hospital in China from January 2016 to December 2018. The SNPs in HTR1A and TPH2, which are related to 5-HT regulation, were selected as indexes to genotype the collected blood samples of participants. Logistic regression was used to analyze the correlation between SNPs of HTR1A and TPH2 with LPE susceptibility, as well as the relationship with leptin, 5-HT and folic acid levels.

Results: The results revealed that HTR1A-rs6295 increased LPE risk in recessive model. Rs11178996 in TPH2 significantly reduced susceptibility to LPE in allelic (odds ratio (OR) = 0.68, 95% confidence interval (95% CI) = 0.49-0.96, p = 0.027), codominant (OR = 0.58, 95% CI = 0.35-0.98, p = 0.040), dominant (OR = 0.58, 95% CI = 0.36-0.92, p = 0.020), and additive (OR = 0.71, 95% CI = 0.52-0.98, p = 0.039) models. Grs11179041Trs10879352 could reduce the risk of LPE (OR = 0.44, 95% CI = 0.22-0.90, p = 0.024) by haplotype analysis.

Conclusion: HTR1A-rs6295 and TPH2-rs11178996 are associated with LPE risk in the Chinese Han population based on the finding of this study.

Keywords: 5-hydroxytryptamine (5-HT); Case-control study; HTR1A; Lifelong premature ejaculation (LPE); Single nucleotide polymorphism (SNP); TPH2.

PubMed Disclaimer

Conflict of interest statement

The authors declared that they have no conflicts of interest.

The authors declare no competing interests.">

Figures

Fig. 1
Fig. 1
Haplotype block map of HTR1A SNPs. Block 1 includes rs878567 and rs6294 with D’ = 1 for the corresponding variants
Fig. 2
Fig. 2
Haplotype block map of TPH2 SNPs. Block 1 includes rs10879346 and rs1386492 with D’ = 1 for the corresponding variants. Block 2 includes rs11179023 and rs7305115 with D’ = 1 for the corresponding variants. Block 3 includes rs11179041 and rs10879352 with D’ = 1 for the corresponding variants

References

    1. Martin C, Nolen H, Podolnick J, Wang R. Current and emerging therapies in premature ejaculation: where we are coming from, where we are going. Int J urology: official J Japanese Urol Association. 2017;24(1):40–50. doi: 10.1111/iju.13202. - DOI - PubMed
    1. Gillman N, Gillman M. Premature ejaculation: aetiology and treatment strategies. Med Sci (Basel, Switzerland). 2019;7(11):102. - PMC - PubMed
    1. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for sexual Medicine Ad Hoc Committee for the definition of premature ejaculation. J Sex Med. 2014;11(6):1423–41. doi: 10.1111/jsm.12524. - DOI - PubMed
    1. Serefoglu EC, Cimen HI, Atmaca AF, Balbay MD. The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. J Sex Med. 2010;7(2 Pt 1):810–5. doi: 10.1111/j.1743-6109.2009.01570.x. - DOI - PubMed
    1. Althof SE, McMahon CG, Waldinger MD, Serefoglu EC, Shindel AW, Adaikan PG, et al. An update of the International Society of sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation (PE) J Sex Med. 2014;11(6):1392–422. doi: 10.1111/jsm.12504. - DOI - PubMed

Supplementary concepts

LinkOut - more resources